{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:01:52Z","timestamp":1793307712835,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00540-022-03107-x","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T19:02:33Z","timestamp":1663354953000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Caution!! Reappearance of remimazolam effect after a flumazenil bolus: a larger bolus of flumazenil and a lower total remimazolam clearance are higher risks"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4702-9874","authenticated-orcid":false,"given":"Kenichi","family":"Masui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"3107_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00540-020-02755-1","volume":"34","author":"K Masui","year":"2020","unstructured":"Masui K. Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!! J Anesth. 2020;34:479\u201382.","journal-title":"J Anesth"},{"key":"3107_CR2","first-page":"636","volume":"132","author":"J Schuttler","year":"2020","unstructured":"Schuttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. Pharmacokinet Clin Pharmacodynam Anesthesiol. 2020;132:636\u201351.","journal-title":"Pharmacokinet Clin Pharmacodynam Anesthesiol"},{"key":"3107_CR3","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/ALN.0000000000003256","volume":"132","author":"S Kheterpal","year":"2020","unstructured":"Kheterpal S, Vaughn MT, Dubovoy TZ, Shah NJ, Bash LD, Colquhoun DA, Shanks AM, Mathis MR, Soto RG, Bardia A, Bartels K, McCormick PJ, Schonberger RB, Saager L. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology. 2020;132:1371\u201381.","journal-title":"Anesthesiology"},{"key":"3107_CR4","first-page":"65","volume":"2","author":"R Amrein","year":"1988","unstructured":"Amrein R, Hetzel W, Hartmann D, Lorscheid T. Clinical pharmacology of flumazenil. Eur J Anaesthesiol Suppl. 1988;2:65\u201380.","journal-title":"Eur J Anaesthesiol Suppl"},{"key":"3107_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF03256937","volume":"31","author":"A Zwiers","year":"2011","unstructured":"Zwiers A, van den Heuve M, Smeets J, Rutherford S. Assessment of the potential for displacement interactions with sugammadex. Clin Drug Investig. 2011;31:101\u201311.","journal-title":"Clin Drug Investig"},{"key":"3107_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/01.anes.0000265152.78943.74","volume":"106","author":"J Sparr Harald","year":"2007","unstructured":"Sparr Harald J, Vermeyen Karel M, Beaufort Anton M, Rietbergen H, Proost Johannes H, Saldien V, Velik-Salchner C, Wierda JMKH. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology. 2007;106:935\u201343.","journal-title":"Anesthesiology"},{"key":"3107_CR7","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s12630-011-9554-y","volume":"58","author":"F Le Corre","year":"2011","unstructured":"Le Corre F, Nejmeddine S, Fatahine C, Tayar C, Marty J, Plaud B. Recurarization after sugammadex reversal in an obese patient. Can J Anesth J Can D\u2019anesth. 2011;58:944.","journal-title":"Can J Anesth J Can D'anesth"},{"key":"3107_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00540-022-03079-y","volume":"36","author":"K Masui","year":"2022","unstructured":"Masui K, St\u00f6hr T, Pesic M, Tonai T. A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice. J Anesth. 2022;36:493\u2013505.","journal-title":"J Anesth"},{"key":"3107_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0009-9236(95)90177-9","volume":"58","author":"P Fiset","year":"1995","unstructured":"Fiset P, Lemmens HL, Egan TE, Shafer SL, Stanski DR. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam. Clin Pharmacol Ther. 1995;58:567\u201382.","journal-title":"Clin Pharmacol Ther"},{"key":"3107_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2147\/DDDT.S186759","volume":"13","author":"N Freyer","year":"2019","unstructured":"Freyer N, Knospel F, Damm G, Greuel S, Schneider C, Seehofer D, Stohr T, Petersen KU, Zeilinger K. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Devel Ther. 2019;13:1033\u201347.","journal-title":"Drug Des Devel Ther"},{"key":"3107_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1399-6576.1994.tb03906.x","volume":"38","author":"TG Short","year":"1994","unstructured":"Short TG, Young KK, Tan P, Tam YH, Gin T, Oh TE. Midazolam and flumazenil pharmacokinetics and pharmacodynamics following simultaneous administration to human volunteers. Acta Anaesthesiol Scand. 1994;38:350\u20136.","journal-title":"Acta Anaesthesiol Scand"},{"key":"3107_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-022-03099-8","author":"K Masui","year":"2022","unstructured":"Masui K, Hagihira S. Equilibration rate constant, ke0, to determine effect-site concentration for the Masui remimazolam population pharmacokinetic model in general anesthesia patients. J Anesth. 2022. https:\/\/doi.org\/10.1007\/s00540-022-03099-8.","journal-title":"J Anesth"},{"key":"3107_CR13","first-page":"60","volume":"107","author":"GJ Kilpatrick","year":"2007","unstructured":"Kilpatrick GJ, McIntyre MS, Cox RF, Stafford JA, Pacofsky GJ, Lovell GG, Wiard RP, Feldman PL, Collins H, Waszczak BL, Tilbrook GS. CNS 7056: a novel Ultra\u2013short-acting Benzodiazepine. Anesthesiolo J Am Soc Anesthesiol. 2007;107:60\u20136.","journal-title":"Anesthesiolo J Am Soc Anesthesiol"},{"key":"3107_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/jcbfm.1993.84","volume":"13","author":"JC Price","year":"1993","unstructured":"Price JC, Mayberg HS, Dannals RF, Wilson AA, Ravert HT, Sadzot B, Rattner Z, Kimball A, Feldman MA, Frost JJ. Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C] flumazenil. J Cereb Blood Flow Metab. 1993;13:656\u201367.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3107_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00540-021-02915-x","volume":"35","author":"T Yamamoto","year":"2021","unstructured":"Yamamoto T, Kurabe M, Kamiya Y. Re-sleeping after reversal of remimazolam by flumazenil. J Anesth. 2021;35:322.","journal-title":"J Anesth"},{"key":"3107_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bja.2021.05.027","volume":"127","author":"T St\u00f6hr","year":"2021","unstructured":"St\u00f6hr T, Colin PJ, Ossig J, Pesic M, Borkett K, Winkle P, Struys MMRF, Schippers F. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. Br J Anaesth. 2021;127:415\u201323.","journal-title":"Br J Anaesth"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-022-03107-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00540-022-03107-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-022-03107-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T08:05:17Z","timestamp":1674461117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00540-022-03107-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3107"],"URL":"https:\/\/doi.org\/10.1007\/s00540-022-03107-x","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"21 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kenichi Masui was a consultant\/advisor for Mundipharma K.K., Tokyo, Japan, and had been awarded a research grant for another study and received payment for delivering domestic lectures from Mundipharma. Additionally, he is an Editor of Journal of Anesthesia, and an Editorial Board of JA Clinical Reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}